Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. H. Whittam
Secondary Antibody Deficiency: A Complication of Anti-Cd20 Therapy for Neuroinflammation
Journal of Neurology
Neurology
Related publications
Anti-Myostatin Antibody Therapy for Myopathies
Clinical Neurology
Neurology
Do We Need Maintenance With Anti-Cd20 Antibody After First-Line Therapy for All Newly Diagnosed Follicular Lymphoma Patients?
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Phase I Study of Chimeric Anti-Cd20 Monoclonal Antibody in Chinese Patients With CD20-positive Non-Hodgkin’s Lymphoma
Chinese Journal of Cancer Research
Cancer Research
Oncology
Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Anti-Cd20 Therapy Depletes Activated Myelin-Specific CD8+ T Cells in Multiple Sclerosis
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Therapy of Advanced B-Lymphoma Xenografts With a Combination of 90y-Anti-Cd22 IgG (Epratuzumab) and Unlabeled Anti-Cd20 IgG (Veltuzumab)
Clinical Cancer Research
Cancer Research
Oncology
Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Inhibition of Increased Circulating TFH Cell by Anti-Cd20 Monoclonal Antibody in Patients With Type 1 Diabetes
PLoS ONE
Multidisciplinary